News | May 11, 2023
AIIA and CCRAS jointly organised session for research and education in Ayush
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The collaboration between CORONA and Ferring will cater to patients across India
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Subscribe To Our Newsletter & Stay Updated
